145 related articles for article (PubMed ID: 1422947)
1. Secular trends in the incidence of postmenopausal vertebral fractures.
Cooper C; Atkinson EJ; Kotowicz M; O'Fallon WM; Melton LJ
Calcif Tissue Int; 1992 Aug; 51(2):100-4. PubMed ID: 1422947
[TBL] [Abstract][Full Text] [Related]
2. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989.
Cooper C; Atkinson EJ; O'Fallon WM; Melton LJ
J Bone Miner Res; 1992 Feb; 7(2):221-7. PubMed ID: 1570766
[TBL] [Abstract][Full Text] [Related]
3. [Vertebral fracture: a major risk factor for osteoporosis].
Krieg MA; Lamy O
Praxis (Bern 1994); 2004 Feb; 93(9):321-8. PubMed ID: 15060973
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis.
Silverman SL; Delmas PD; Kulkarni PM; Stock JL; Wong M; Plouffe L
J Am Geriatr Soc; 2004 Sep; 52(9):1543-8. PubMed ID: 15341559
[TBL] [Abstract][Full Text] [Related]
5. Vertebral fracture in postmenopausal Chinese women: a population-based study.
Cui L; Chen L; Xia W; Jiang Y; Cui L; Huang W; Wang W; Wang X; Pei Y; Zheng X; Wang Q; Ning Z; Li M; Wang O; Xing X; Lin Q; Yu W; Weng X; Xu L; Cummings SR
Osteoporos Int; 2017 Sep; 28(9):2583-2590. PubMed ID: 28560474
[TBL] [Abstract][Full Text] [Related]
6. Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk.
Boonen S; Adachi JD; Man Z; Cummings SR; Lippuner K; Törring O; Gallagher JC; Farrerons J; Wang A; Franchimont N; San Martin J; Grauer A; McClung M
J Clin Endocrinol Metab; 2011 Jun; 96(6):1727-36. PubMed ID: 21411557
[TBL] [Abstract][Full Text] [Related]
7. Vertebral fractures predict subsequent fractures.
Melton LJ; Atkinson EJ; Cooper C; O'Fallon WM; Riggs BL
Osteoporos Int; 1999; 10(3):214-21. PubMed ID: 10525713
[TBL] [Abstract][Full Text] [Related]
8. No secular increase in the prevalence of vertebral fractures due to postmenopausal osteoporosis.
Hansen MA; Overgaard K; Nielsen VA; Jensen GF; Gotfredsen A; Christiansen C
Osteoporos Int; 1992 Sep; 2(5):241-6. PubMed ID: 1392263
[TBL] [Abstract][Full Text] [Related]
9. Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
Bouxsein ML; Chen P; Glass EV; Kallmes DF; Delmas PD; Mitlak BH
J Bone Joint Surg Am; 2009 Jun; 91(6):1329-38. PubMed ID: 19487509
[TBL] [Abstract][Full Text] [Related]
10. [No increase in the prevalence of vertebral fractures among postmenopausal women over a 10-year period].
Hansen MA; Overgaard K; Nielsen VA; Jensen G; Gotfredsen A; Christiansen C
Ugeskr Laeger; 1993 Aug; 155(31):2392-6. PubMed ID: 8346589
[TBL] [Abstract][Full Text] [Related]
11. Frequency, distribution and severity of prevalent osteoporotic vertebral fractures in postmenopausal women.
Kilincer C; Kabayel DD; Cagli B; Unlu E; Wicki B; Ozdemir F
Turk Neurosurg; 2013; 23(4):476-83. PubMed ID: 24101267
[TBL] [Abstract][Full Text] [Related]
12. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
[TBL] [Abstract][Full Text] [Related]
13. [Rheumatology and osteoporosis (RETOSS): a vision of postmenopausal osteoporosis in rheumatology departments throughout Spain].
Bernad Pineda M; González Fernández CM; Fernández Prada M; Fernández Campillo J; Maeso Martín R; Garcés Puentes MV
Reumatol Clin; 2011; 7(1):13-9. PubMed ID: 21794774
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: estimations from a disease model.
Cawston H; Maravic M; Fardellone P; Gauthier A; Kanis JA; Compston J; Borgström F; Cooper C; McCloskey E
Arch Osteoporos; 2012; 7():237-46. PubMed ID: 23060309
[TBL] [Abstract][Full Text] [Related]
15. The population-based prevalence of osteoporotic vertebral fracture and densitometric osteoporosis in postmenopausal women over 50 in Valencia, Spain (the FRAVO study).
Sanfélix-Genovés J; Reig-Molla B; Sanfélix-Gimeno G; Peiró S; Graells-Ferrer M; Vega-Martínez M; Giner V
Bone; 2010 Sep; 47(3):610-6. PubMed ID: 20601286
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: the study of osteoporotic fractures.
Nevitt MC; Cummings SR; Stone KL; Palermo L; Black DM; Bauer DC; Genant HK; Hochberg MC; Ensrud KE; Hillier TA; Cauley JA
J Bone Miner Res; 2005 Jan; 20(1):131-40. PubMed ID: 15619679
[TBL] [Abstract][Full Text] [Related]
17. Risk of new vertebral fracture in the year following a fracture.
Lindsay R; Silverman SL; Cooper C; Hanley DA; Barton I; Broy SB; Licata A; Benhamou L; Geusens P; Flowers K; Stracke H; Seeman E
JAMA; 2001 Jan; 285(3):320-3. PubMed ID: 11176842
[TBL] [Abstract][Full Text] [Related]
18. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study.
Chang KP; Center JR; Nguyen TV; Eisman JA
J Bone Miner Res; 2004 Apr; 19(4):532-6. PubMed ID: 15005838
[TBL] [Abstract][Full Text] [Related]
19. Secular trends in the incidence of hip fractures.
Melton LJ; O'Fallon WM; Riggs BL
Calcif Tissue Int; 1987 Aug; 41(2):57-64. PubMed ID: 3115545
[TBL] [Abstract][Full Text] [Related]
20. Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple Outcomes of Raloxifene Evaluation.
Siris E; Adachi JD; Lu Y; Fuerst T; Crans GG; Wong M; Harper KD; Genant HK
Osteoporos Int; 2002 Nov; 13(11):907-13. PubMed ID: 12415439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
